Soluble tumor necrosis factor receptor I, Ii
Takemura, M.; Saito, K.; Seishima, M.
Nihon Rinsho. Japanese Journal of Clinical Medicine 63(Suppl 8): 158-160
2005
ISSN/ISBN: 0047-1852 PMID: 16149477 Document Number: 594441
Document emailed within 1 workday
Related Documents
Nassonov, E.L.; Samsonov, M.Y.; Tilz, G.P.; Beketova, T.V.; Semenkova, E.N.; Baranov, A.; Wachter, H.; Fuchs, D. 1997: Serum concentrations of neopterin, soluble interleukin 2 receptor, and soluble tumor necrosis factor receptor in Wegener's granulomatosis Journal of Rheumatology 24(4): 666-670Maroushek Boury, N.; Bosworth, B.T.; Stabel, T.J.; Kehrli, M.E.; Taylor, M.J. 1998: Cloning and expression of porcine recombinant soluble tumor necrosis factor receptor 1 American Journal of Veterinary Research 59(10): 1317-1322
Fujikawa, K.; Kawakami, A.; Eguchi, K. 2007: Etanercept: recombinant human soluble tumor necrosis factor receptor fusion protein Nihon Rinsho. Japanese Journal of Clinical Medicine 65(7): 1211-1217
Alekperov, R.T.; Timchenko, A.V.; Samsonov, M.I.; Guseva, N.G.; Nasonov, E.L. 2004: Level of soluble tumor necrosis factor receptor type i in patients with systemic scleroderma Terapevticheskii Arkhiv 76(5): 11-15
Rullan, P.; Murase, J. 2009: Two cases of chronic atopic dermatitis treated with soluble tumor necrosis factor receptor therapy Journal of Drugs in Dermatology: Jdd 8(9): 873-876
Alsalameh, S.; Mattka, B.; Al-Ward, R.; Lorenz, H.M.; Manger, B.; Pfizenmaier, K.; Grell, M.; Kalden, J.R. 1999: Preferential expression of tumor necrosis factor receptor 55 (TNF-R55) on human articular chondrocytes: selective transcriptional upregulation of TNF-R75 by proinflammatory cytokines interleukin 1beta, tumor necrosis factor-alpha, and basis fibroblast growth factor Journal of Rheumatology 26(3): 645-653
He, S.; Huang, H. 1997: Monocyte tumor necrosis factor and tumor necrosis factor receptor expression in patients with alcoholic liver cirrhosis Zhonghua Nei Ke Za Zhi 36(8): 526-528
Sundrarjun, T.; Komindr, S.; Archararit, N.; Dahlan, W.; Puchaiwatananon, O.; Angthararak, S.; Udomsuppayakul, U.; Chuncharunee, S. 2004: Effects of n-3 fatty acids on serum interleukin-6, tumour necrosis factor-alpha and soluble tumour necrosis factor receptor p55 in active rheumatoid arthritis Journal of International Medical Research 32(5): 443-454
Suzuki, Y.; Chen, L.P.; Liu, C.M.; Morita, T.; Wheelock, E.F. 1989: Immune regulation of the L5178Y murine tumor-dormant state: induction of cell- and soluble factor-mediated inhibition of tumor cell growth by tumor necrosis factor and gamma-interferon Cancer Research 49(8): 2028-2033
Broudy, V.C.; Harlan, J.M.; Adamson, J.W. 1987: Disparate effects of tumor necrosis factor-alpha/cachectin and tumor necrosis factor-beta/lymphotoxin on hematopoietic growth factor production and neutrophil adhesion molecule expression by cultured human endothelial cells Journal of Immunology 138(12): 4298-4302
Krichevskaia, O.A.; Kliukvina, N.G.; Aleksandrova, E.N.; Samsonov, M.I.; Nasonov, E.L. 2004: Clinical value of soluble tumor necrosis factor-alpha receptors in patients with systemic lupus erythematosus Klinicheskaia Meditsina 82(10): 51-55
Schmidt, K.L. 2000: Whole body hyperthermia induction of soluble tumor necrosis factor receptors: implications for rheumatoid diseases Journal of Rheumatology 27(9): 2281-2282
Hori, K.; Ehrke, M.J.; Mace, K.; Mihich, E. 1987: Effect of recombinant tumor necrosis factor on tumoricidal activation of murine macrophages: synergism between tumor necrosis factor and gamma-interferon Cancer Research 47(22): 5868-5874
Kokot, T.; Muc-Wierzgoń, M.; Zubelewicz, B.; Wierzgoń, J.; Nowakowska, E.; Brodziak, A. 2000: Soluble tumor necrosis factor receptors--their properties and role in diagnosis and therapy of acute and chronic diseases Postepy Higieny i Medycyny Doswiadczalnej 54(5): 585-596
Pussieldi, G.A.; Gomes, E.C.; Veneroso, C.E.; De Paz, J.A.; Fonseca, T.R.; Mendes, T.T.; Rossi, A.G.; Teixeira, M.M.; Teixeira, A.L.; Alessandri, A.L. 2014: Soluble tumour necrosis factor receptor-1 (sTNFR1) levels are positively associated with exercise intensity in athletes after strenuous off-road cycling Journal of Sports Medicine and Physical Fitness 54(2): 225-231
Bemelmans, M.H.; Gouma, D.J.; Buurman, W.A. 1993: LPS-induced sTNF-receptor release in vivo in a murine model. Investigation of the role of tumor necrosis factor, IL-1, leukemia inhibiting factor, and IFN-gamma Journal of Immunology 151(10): 5554-5562
Sorkine, P.; Setton, A.; Halpern, P.; Miller, A.; Rudick, V.; Marmor, S.; Klausner, J.M.; Goldman, G. 1995: Soluble tumor necrosis factor receptors reduce bowel ischemia-induced lung permeability and neutrophil sequestration Critical Care Medicine 23(8): 1377-1381
García, M.Martin.; De Rissio, A.Maria.; Villalonga, X.; Mengoni, E.; Cardoni, R.L. 2008: Soluble tumor necrosis factor (TNF) receptors (sTNF-R1 and -R2) in pregnant women chronically infected with Trypanosoma cruzi and their children American Journal of Tropical Medicine and Hygiene 78(3): 499-503
Kacprzyk, F. 2002: Serum levels and urinary excretion of soluble receptors for tumor necrosis factor (sTNF R) in patients with primary glomerulonephritis Polskie Archiwum Medycyny Wewnetrznej 107(3): 215-221
Himeno, T.; Watanabe, N.; Yamauchi, N.; Maeda, M.; Tsuji, Y.; Okamoto, T.; Neda, H.; Niitsu, Y. 1990: Expression of endogenous tumor necrosis factor as a protective protein against the cytotoxicity of exogenous tumor necrosis factor Cancer Research 50(16): 4941-4945